UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 8, 2019

 

LIQUIDIA TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-38601

 

20-1926605

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

419 Davis Drive, Suite 100, Morrisville, North Carolina

 

27560

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (919) 328-4400

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common stock

 

LQDA

 

Nasdaq Capital Market

 

 

 


 

Item 5.02                                           Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

As previously disclosed, immediately prior to the conclusion of the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) held on May 8, 2019, Edward Mathers formally resigned as a Class I director of Liquidia Technologies, Inc., a Delaware corporation (the “Company”), and as a member of the Company’s Compensation Committee and Nominating and Corporate Governance Committee.  Mr. Mathers served as (i) a director of the Company since July 2009, (ii) a member of the Company’s Compensation Committee since its formation in August 2016 and (iii) a member of the Company’s Nominating and Corporate Governance Committee since its formation in July 2018.  No disagreement with the Company caused, in whole or in part, Mr. Mathers’ refusal to stand for re-election at the Annual Meeting.

 

Item 5.07                                           Submission of Matters to a Vote of Security Holders

 

The Company held its Annual Meeting on May 8, 2019.  At the Annual Meeting, the following matters were submitted to a vote of stockholders:

 

1.              The election of two (2) Class I directors to serve until the Company’s 2022 Annual Meeting of Stockholders, or until their respective successors shall have been duly elected and qualified;

 

2.              The approval of the Liquidia Technologies, Inc. 2019 Employee Stock Purchase Plan (the “Plan”); and

 

3.              The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019.

 

At the close of business on March 15, 2019, the record date for the determination of stockholders entitled to vote at the Annual Meeting, there were 15,632,406 shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), outstanding and entitled to vote at the Annual Meeting. The holders of 11,560,483 shares of the Company’s Common Stock were represented in person or by proxy at the Annual Meeting, constituting a quorum.

 

At the Annual Meeting, the two directors were elected, the Plan was approved, and the appointment of the Company’s independent registered public accounting firm for the year ending December 31, 2019 was ratified.

 

Proposal No. 1— Election of Class I Directors

 

The vote with respect to the election of Class I directors was as follows:

 

Nominees

 

For

 

Withheld

 

Broker Non-
Votes

 

Dr. Stephen Bloch

 

9,088,066

 

70,313

 

2,402,104

 

Dr. Ralph Snyderman

 

8,853,856

 

304,523

 

2,402,104

 

 

Proposal No. 2 — Approval of the Liquidia Technologies, Inc. 2019 Employee Stock Purchase Plan

 

The vote with respect to the approval of the Plan was as follows:

 

For

 

Against

 

Abstain

 

Broker Non-
Votes

 

8,434,277

 

724,051

 

51

 

2,402,104

 

 

2


 

Proposal No. 3 — Ratification of the Appointment of Independent Registered Public Accounting Firm

 

The vote with respect to the ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019 was as follows:

 

For

 

Against

 

Abstain

 

11,556,879

 

459

 

3,145

 

 

3


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

May 8, 2019

ADMA Biologics, Inc.

 

 

 

 

 

By:

/s/ Timothy Albury

 

 

Name: Timothy Albury

 

 

Title:   Interim Chief Financial Officer

 

4